库拉肿瘤 KURA
$7.27 +$0.47 (+6.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.27 0.00%
开盘$6.91
昨收$6.80
当日区间$6.75 – $7.40
成交量3.09M
市值$646.74M
市盈率（TTM）–
股息率–
财报
财报日平均波动±2.6%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+8.3%
最差反应-7.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 12 Aug 2026 | After Market | ±12.6% | +1.51% | 符合区间 |
| 2026/Q1 | 12 May 2026 | After Market | ±34.9% | -2.07% | 符合区间 |
| 2025/Q4 | 5 Mar 2026 | Pre Market | ±14.6% | -0.47% | 符合区间 |
| 2025/Q3 | 4 Nov 2025 | Pre Market | ±17.6% | +1.94% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±30.2% | -7.05% | 符合区间 |
| 2025/Q1 | 1 May 2025 | After Market | – | -0.31% | – |
| 2024/Q4 | 26 Feb 2025 | After Market | ±15.4% | -1.54% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | After Market | ±30.4% | -0.51% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±15.8% | -0.78% | 符合区间 |
| 2024/Q1 | 2 May 2024 | After Market | ±12.7% | +0.19% | 符合区间 |
| 2023/Q4 | 27 Feb 2024 | After Market | ±17.5% | -1.75% | 符合区间 |
| 2023/Q3 | 2 Nov 2023 | After Market | – | +7.01% | – |
| 2023/Q2 | 3 Aug 2023 | After Market | ±15.2% | +4.36% | 符合区间 |
| 2023/Q1 | 10 May 2023 | After Market | ±12.8% | +8.30% | 符合区间 |
| 2022/Q4 | 23 Feb 2023 | After Market | ±9.6% | -2.74% | 符合区间 |
| 2022/Q3 | 3 Nov 2022 | Pre Market | ±26.9% | -1.67% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$20.87M+36.5% YoY
营业利润-$73.01M-0.5% YoY
净利润-$68.33M-3.3% YoY
摊薄每股收益-$0.77-2.7% YoY
自由现金流-$63.21M-109.0% YoY
经营现金流-$62.55M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率99.3%
营业利润率-411.9%
净利率-384.3%
净资产收益率-167.7%
资产收益率-46.7%
投入资本回报率-155.6%
流动比率4.73
负债/资产比率91.8%
现金及投资$519.03M
总负债$23.16M
净现金（净负债）$495.86M
暂无评论——快来第一个聊聊 KURA。
登录后参与讨论。